SMAD2 and oral cavity squamous cell carcinoma: Moreover, previous research demonstrated that miR-149-5p increased the chemosensitivity of cisplatin on oral squamous cell carcinoma via inhibiting TGF-β2, p-Smad2, and p-Smad3 (Luo et al., 2019).